Mangalam Drugs And Organics Limited (MANGALAM) — Announcement
Mangalam Drugs & Organics disclosed the resignation of Company Secretary Anuradha Pandey, effective March 29, 2026, after an administrative delay in filing the required disclosure under SEBI LODR Regulation 30. The resignation was submitted late due to an oversight, but the company promptly filed the revised paperwork. This event highlights procedural compliance risks and leadership transition concerns for investors.
About Mangalam Drugs And Organics Limited (MANGALAM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when MANGALAM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track MANGALAM — Free💡 Ask AI about this filing
📊 More MANGALAM filings
- share transfer — 13 July 2026 Mangalam Drugs and Organics Limited received a compliance certificate from MUFG Intime India Private...
- 🔴 Announcement — 17 June 2026 No summary available
- 🔴 Announcement — 17 June 2026 No summary available
- 🔴 Announcement — 16 May 2026 Mangalam Drugs and Organics Limited disclosed a loan default exceeding 30 days on obligations to Ban...
- 🔴 Announcement — 21 April 2026 No summary available
🔥 Also filed on 17 April 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when MANGALAM files new disclosures
Track MANGALAM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track MANGALAM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research